Literature DB >> 2186633

Kinetics and Na independence of amino acid uptake by blood side of perfused sheep choroid plexus.

M B Segal1, J E Preston, C S Collis, B V Zlokovic.   

Abstract

The kinetic constants and sodium independence of amino acid uptake by the basolateral face (blood side) of the isolated perfused choroid plexus of the sheep were investigated. Uptake of 3H-labeled L-alanine, glycine, L-glutamine, L-leucine, L-glutamate, and L-lysine was not significantly inhibited when the sodium level of the perfusate was lowered to less than 6 mM. The cerebrospinal fluid (CSF) secretion rate was, however, reduced by 65.6%. The Michaelis constants for L-serine, glycine, L-phenylalanine, L-glutamate, and L-arginine were measured and varied between 25.4 microM for L-arginine and 2.6 microM for L-glutamate. The Vmax for the amino acids varied by about the same range as Km, with L-serine having the highest Vmax of 28.8 nmol.min-1.g-1, and L-phenylalanine having the lowest at 4.6 nmol.min-1.g-1. At normal plasma concentrations of 30-155 microM for individual amino acids, the carriers for glycine, L-phenylalanine, and L-glutamate would be almost fully saturated (greater than 90%), while those for L-serine and L-arginine would be greater than 60% saturated. This restricted uptake of amino acids by the basolateral face of the choroid plexus, coupled to clearance of these substances out of the CSF (5), could account for the low levels in the CSF compared with that in the plasma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186633     DOI: 10.1152/ajprenal.1990.258.5.F1288

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics.

Authors:  N Strazielle; J F Ghersi-Egea
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Transport of prion protein across the blood-brain barrier.

Authors:  W A Banks; Sandra M Robinson; R Diaz-Espinoza; A Urayama; C Soto
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

Review 3.  The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.

Authors:  R Deane; A Sagare; B V Zlokovic
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

4.  Localisation of novel forms of glutamate transporters and the cystine-glutamate antiporter in the choroid plexus: Implications for CSF glutamate homeostasis.

Authors:  Aven Lee; Ashley R Anderson; Andrew J Rayfield; Melissa G Stevens; Philip Poronnik; James S Meabon; David G Cook; David V Pow
Journal:  J Chem Neuroanat       Date:  2011-09-29       Impact factor: 3.052

5.  Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.

Authors:  Abhay P Sagare; Rashid Deane; Henrik Zetterberg; Anders Wallin; Kaj Blennow; Berislav V Zlokovic
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Characterization of the amino acid transport of new immortalized choroid plexus epithelial cell lines: a novel in vitro system for investigating transport functions at the blood-cerebrospinal fluid barrier.

Authors:  T Kitazawa; K Hosoya; M Watanabe; T Takashima; S Ohtsuki; H Takanaga; M Ueda; N Yanai; M Obinata; T Terasaki
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

7.  Permeability of the blood-brain barrier to a rhenacarborane.

Authors:  Patrick M Hawkins; Paul A Jelliss; Naoko Nonaka; Xiaoming Shi; William A Banks
Journal:  J Pharmacol Exp Ther       Date:  2009-01-29       Impact factor: 4.030

Review 8.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

Review 9.  New therapeutic targets in the neurovascular pathway in Alzheimer's disease.

Authors:  Berislav V Zlokovic
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

Review 10.  Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Authors:  Robert D Bell; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2009-03-25       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.